$ cat ./records/gates-meets-president-xi-jinping-foundation-pledges-50-million-to-2023.txt
Gates Meets President Xi Jinping; Foundation Pledges $50 Million to Tsinghua Drug Discovery Institute
[RECORD.TXT] · cat --full
Gates visited China for the first time since 2019, meeting privately with President Xi Jinping, who greeted him as 'an old friend.' The visit focused on global health and agricultural development. Simultaneously, the Gates Foundation announced a renewed five-year $50 million commitment to the Global Health Drug Discovery Institute at Tsinghua University, to be matched by the Beijing Municipal Government — bringing the total to $100 million. Gates was among the first major Western business figures to meet Xi following the pandemic.
Source: https://fortune.com/asia/2023/06/16/xi-jinping-bill-gates-old-friend-beijing-visit-50-million-gift/
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Invests $40 Million to Accelerate mRNA Vaccine Manufacturing in Africa
Next →
Backed UPSIDE Foods — first USDA-approved cultivated chicken receives regulatory green light
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.